AJ, U., AP, B., N, K., T, S., AA, O., D, D., & JM, G. (2019). Cobimetinib and trametinib inhibit platelet MEK but do not cause platelet dysfunction. Platelets, 30(6), 762. https://doi.org/10.1080/09537104.2018.1514107
Chicago Style (17th ed.) CitationAJ, Unsworth, Bye AP, Kriek N, Sage T, Osborne AA, Donaghy D, and Gibbins JM. "Cobimetinib and Trametinib Inhibit Platelet MEK but Do Not Cause Platelet Dysfunction." Platelets 30, no. 6 (2019): 762. https://doi.org/10.1080/09537104.2018.1514107.
MLA (9th ed.) CitationAJ, Unsworth, et al. "Cobimetinib and Trametinib Inhibit Platelet MEK but Do Not Cause Platelet Dysfunction." Platelets, vol. 30, no. 6, 2019, p. 762, https://doi.org/10.1080/09537104.2018.1514107.
Warning: These citations may not always be 100% accurate.